[RESEARCH BLOG] · 2026-08-26

Rocket Lab (RKLB) Faces **SELL** Signal Amid Crisis Regime as Revenue Surges but Margins Pressure

By Pierre Brunelle · Founder & Research Lead

RKLBSELLCRISISsell flip

Rocket Lab USA, Inc. (NASDAQ: RKLB) closed 2026‑08‑25 at $66.91, a decline of 2.01 % from the prior session. The LOPJLB proprietary scanner now flags a SELL directional signal with a CRISIS market‑regime rating, assigning the stock a composite score of ‑5.

News / Catalysts

Fundamentals and Valuation

Rocket Lab’s valuation metrics remain deeply distorted by its high‑growth, loss‑making profile. The trailing twelve‑month (TTM) price‑to‑earnings ratio sits at ‑243.1, reflecting a sizable net loss that dwarfs the modest revenue base. The price‑to‑book multiple of 12.14 suggests the market is pricing the firm well above its book value, a stance that aligns with the “growth‑over‑value” bias evident in many aerospace start‑ups.

Enterprise value to EBITDA is equally extreme at ‑303.4, underscoring that adjusted EBITDA remains negative despite recent revenue acceleration. Return on invested capital (ROIC) is ‑4.53 %, while return on equity (ROE) and return on assets (ROA) are ‑7.56 % and ‑3.95 %, respectively, confirming that profitability is still in the negative territory.

Margin analysis reveals a mixed picture. Gross margin has improved to 37.26 %, driven by higher launch‑service pricing and cost efficiencies in the Electron production line. However, operating margin is ‑29.06 %, and net margin sits at ‑21.51 %, indicating that SG&A, R&D, and the nascent Neutron program are still weighing heavily on the bottom line.

The balance sheet shows a debt‑to‑equity ratio of 3.83, reflecting a capital structure that leans heavily on debt financing to fund its aggressive expansion and acquisition strategy. Analysts collectively assign a Buy rating with a median price target of $116.1, implying a potential upside of roughly 73 % from the current price level.

MetricValue
P/E (TTM)‑243.1
P/B12.14
EV/EBITDA‑303.4
Gross Margin (%)37.26
Operating Margin (%)‑29.06
Net Margin (%)‑21.51
D/E Ratio3.83
Analyst Target ($)116.1

Revenue growth has been the most compelling narrative in recent quarters. In Q2 2025, Rocket Lab posted $144.5 million in revenue, a 48 % year‑over‑year increase. That momentum accelerated to $155 million in Q3 2025 and exploded to $602 million in Q4 2025, representing a 38 % jump from the prior quarter and a 317 % increase versus the same quarter a year earlier. The Q1 2026 quarter continued the upward trajectory, delivering a record revenue figure (exact dollar amount not disclosed in the call transcript) and a GAAP gross margin of 38.2 %, the highest in company history.

Backlog expansion mirrors the revenue surge. By the end of Q4 2025, the backlog stood at $1.85 billion, a 73 % rise from the previous quarter, and grew further to exceed $2 billion in Q1 2026. This backlog includes 31 Electron/HASTE missions, five dedicated Neutron contracts, and a $190 million 20‑launch HASTE order from the Department of War, underscoring the firm’s deepening ties with U.S. defense customers.

Despite the revenue and backlog strength, the company’s cost structure is beginning to feel the strain of larger, lower‑margin contracts. The Service Development Agreement (SDA) tranche III award of $816 million—secured in Q4 2025—will introduce a higher proportion of defense‑related work that historically carries thinner margins. Management’s Q2 2026 guidance anticipates GAAP gross margins slipping to 33‑35 % and non‑GAAP margins to 38‑40 %, reflecting the anticipated mix shift.

Cash remains a bright spot. At the close of Q1 2026, Rocket Lab reported $1.48 billion in cash and equivalents, with total liquidity exceeding $2 billion after equity offerings and forward transactions. This cash cushion supports ongoing Neutron development, the integration of recent acquisitions (Motive Space Systems and Mynaric), and capital‑expenditure plans that remain modest at $27.1 million for the quarter.

Overall, the fundamentals paint a picture of a company in rapid expansion, trading at lofty multiples while still generating negative earnings. The valuation reflects both the optimism surrounding its launch cadence and the uncertainty tied to its heavy‑lift Neutron program and defense‑funded contracts.

Earnings Call

Rocket Lab’s most recent earnings discussion, covering the first quarter of 2026, reinforced the narrative of accelerating commercial demand paired with emerging execution risks. Management highlighted a record Q1 revenue figure (exact amount undisclosed) and record GAAP gross margin of 38.2 %, alongside a backlog exceeding $2 billion—a 20 % quarter‑over‑quarter increase. The company also announced two strategic acquisitions: Motive Space Systems, which adds robotics and spacecraft mechanisms, and Mynaric, a supplier of laser‑communication technology.

Guidance for the second quarter was maintained, with revenue projected in the $225 million to $240 million range and margin expectations adjusted downward to 33‑35 % GAAP and 38‑40 % non‑GAAP. Management attributed the margin softening to the upcoming integration of SDA contracts, which historically carry lower profitability, and to higher spending on Neutron development.

The tone of the call was notably upbeat. The management‑tone score registered at 0.80, indicating strong confidence. A highlighted quote from the CEO, Sir Peter Beck, captured this sentiment:

“This quarter has been phenomenal, the strongest Q1 in Rocket Labs history. We've blown through the ceilings across all of the most important metrics, record revenue, record GAAP gross margins, record backlog, record cash position and…”

The same speaker added a cautionary note on technical risk:

“The key things to be watching out for the continued placing of items on test stands because really, that's the large pieces of work yet to come that have risk associated with them.”

Adjusted EBITDA for Q1 2026 posted a loss of $11.8 million, comfortably beating the guidance range of a $21 million to $27 million loss. This improvement was driven by higher revenue and better gross margins, even as operating expenses rose to support Neutron testing and the integration of new acquisitions.

Management also outlined several forward‑looking milestones. The Neutron multi‑launch contract now includes five dedicated flights plus three Electron rides through 2029, representing the largest contract in the company’s history. The HASTE 20‑launch order with Kratos, valued at $190 million, is on track, and the Space‑Based Interceptor program under the Golden Dome initiative has been selected with Raytheon, signaling deeper defense collaboration.

However, the call did not shy away from risk factors. Technical risk remains centered on the Neutron stage‑1 tank design, which suffered a rupture that delayed the first flight to Q4 2026. Market risk stems from the company’s heavy reliance on defense and SDA funding; any shift in government budgets could materially affect revenue streams. Pricing risk is also present, as the firm must preserve Neutron’s average selling price without resorting to discounting, a challenge that has historically affected the Electron line. Finally, integration risk accompanies the recent acquisitions, with cultural and execution hurdles that could impact near‑term performance.

In sum, the earnings narrative paints a picture of a firm that has turned revenue growth into record cash and backlog levels, yet now faces the classic scaling challenges of margin compression, technical execution, and dependence on government contracts.

LOPJLB Signal Read

The LOPJLB scanner currently assigns RKLB a SELL directional signal and places the stock in a CRISIS market regime. The composite PERF score stands at 18.30, while the FUND quality score is 6.59. The model rates the stock as Balanced on the Value‑Growth‑GARP‑Quality spectrum (V = 9.00, G = 4.00, GARP = 6.40, Q = 6.59).

Readers can explore the full overlay of technical and quantitative signals on the interactive chart above this article, and review the underlying methodology at the LOPJLB methodology page.

Further research

The information provided herein is for research purposes only and does not constitute investment advice. All opinions are those of the author and are subject to change without notice.

This post is independent quantitative research, not investment advice. LOPJLB signals are model outputs derived from price, volume, and fundamentals. Past backtests do not guarantee future results. Position sizing, execution, and risk management remain the reader's responsibility.

Open RKLB signal detail → · Open screener → · Methodology